1. Home
  2. IMAB vs EVI Comparison

IMAB vs EVI Comparison

Compare IMAB & EVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • EVI
  • Stock Information
  • Founded
  • IMAB 2014
  • EVI 1959
  • Country
  • IMAB United States
  • EVI United States
  • Employees
  • IMAB N/A
  • EVI N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • EVI Other Consumer Services
  • Sector
  • IMAB Health Care
  • EVI Consumer Discretionary
  • Exchange
  • IMAB Nasdaq
  • EVI Nasdaq
  • Market Cap
  • IMAB 200.9M
  • EVI 236.3M
  • IPO Year
  • IMAB 2020
  • EVI N/A
  • Fundamental
  • Price
  • IMAB $2.29
  • EVI $22.99
  • Analyst Decision
  • IMAB Strong Buy
  • EVI Strong Buy
  • Analyst Count
  • IMAB 2
  • EVI 1
  • Target Price
  • IMAB $6.00
  • EVI $28.00
  • AVG Volume (30 Days)
  • IMAB 1.0M
  • EVI 29.9K
  • Earning Date
  • IMAB 05-15-2025
  • EVI 05-12-2025
  • Dividend Yield
  • IMAB N/A
  • EVI 1.34%
  • EPS Growth
  • IMAB N/A
  • EVI 29.85
  • EPS
  • IMAB N/A
  • EVI 0.48
  • Revenue
  • IMAB N/A
  • EVI $370,020,000.00
  • Revenue This Year
  • IMAB N/A
  • EVI $25.04
  • Revenue Next Year
  • IMAB N/A
  • EVI N/A
  • P/E Ratio
  • IMAB N/A
  • EVI $48.07
  • Revenue Growth
  • IMAB N/A
  • EVI 3.51
  • 52 Week Low
  • IMAB $0.60
  • EVI $14.51
  • 52 Week High
  • IMAB $3.08
  • EVI $23.70
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 53.66
  • EVI 73.98
  • Support Level
  • IMAB $2.00
  • EVI $19.57
  • Resistance Level
  • IMAB $2.95
  • EVI $23.70
  • Average True Range (ATR)
  • IMAB 0.35
  • EVI 1.16
  • MACD
  • IMAB -0.07
  • EVI 0.39
  • Stochastic Oscillator
  • IMAB 30.53
  • EVI 87.52

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About EVI EVI Industries Inc.

EVI Industries Inc through its subsidiaries, is a distributor that sells, leases, and rents commercial, industrial, and vended laundry and dry cleaning equipment and steam and hot water boilers manufactured by others, supplies related replacement parts and accessories, designs and plans turn-key laundry, dry cleaning, and boiler systems, and provides installation and maintenance services to its customers, which include commercial, industrial, institutional, government, and retail customers. These activities are conducted in the United States, Canada, the Caribbean, and Latin America.

Share on Social Networks: